Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Suppression of herpes simplex virus infections with oral lithium carbonate--a possible antiviral activity.

Amsterdam JD, Maislin G, Hooper MB.

Pharmacotherapy. 1996 Nov-Dec;16(6):1070-5.

PMID:
8947995
2.

Reduced rate of recurrent genital herpes infections with lithium carbonate.

Amsterdam JD, Maislin G, Potter L, Giuntoli R.

Psychopharmacol Bull. 1990;26(3):343-7.

PMID:
2125737
3.

An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.

Fife KH, Warren TJ, Justus SE, Heitman CK; HS2100275 STUDY TEAM.

Sex Transm Dis. 2008 Jul;35(7):668-73. doi: 10.1097/OLQ.0b013e31816d1f42.

PMID:
18461016
4.
5.

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.

J Infect Dis. 2007 Nov 15;196(10):1500-8. Epub 2007 Oct 31.

PMID:
18008230
6.

Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis.

Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A.

Dermatologica. 1987;175(4):183-90.

PMID:
3115841
7.

[Labial herpes in patients with affective disorders receiving long-term lithium carbonate].

Rybakowski J, Strzyzewski W, Zelechowska-Ruda E, Chłopocka-Woźniak M.

Pol Tyg Lek. 1993 Mar 1-8;48(9-10):215-7. Polish.

PMID:
8234051
8.
9.

A clinical pilot study of lignin--ascorbic acid combination treatment of herpes simplex virus.

Lopez BS, Yamamoto M, Utsumi K, Aratsu C, Sakagami H.

In Vivo. 2009 Nov-Dec;23(6):1011-6.

10.

[Mother-infant and indirect transmission of HSV infection: treatment and prevention].

Henrot A.

Ann Dermatol Venereol. 2002 Apr;129(4 Pt 2):533-49. Review. French.

PMID:
12122323
11.
12.

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.

Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L.

Clin Infect Dis. 2002 Apr 1;34(7):944-8. Epub 2002 Feb 20.

PMID:
11880960
13.

Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.

DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA; Valacyclovir International HSV Study Group.

J Infect Dis. 2003 Oct 1;188(7):1009-16. Epub 2003 Sep 10. Erratum in: J Infect Dis. 2003 Nov 1;188(9):1404.

PMID:
14513421
14.

Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.

Warren T, Harris J, Brennan CA.

Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S258-66.

PMID:
15494897
15.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
16.

Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.

Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY; Topical Penciclovir Clinical Study Group.

J Dermatolog Treat. 2002 Jun;13(2):67-72.

PMID:
12060504
17.

Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC Jr, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.

Clin Ther. 2007 Aug;29(8):1579-90; discussion 1577-8.

PMID:
17919541
18.

Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.

Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.

J Infect Dis. 2004 Oct 15;190(8):1374-81. Epub 2004 Sep 20.

PMID:
15378428
19.

PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.

Keller MJ, Zerhouni-Layachi B, Cheshenko N, John M, Hogarty K, Kasowitz A, Goldberg CL, Wallenstein S, Profy AT, Klotman ME, Herold BC.

J Infect Dis. 2006 Jan 1;193(1):27-35. Epub 2005 Nov 17.

PMID:
16323128
20.

Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.

Hayden FG, Coats T, Kim K, Hassman HA, Blatter MM, Zhang B, Liu S.

Antivir Ther. 2002 Mar;7(1):53-65.

PMID:
12008788

Supplemental Content

Support Center